BMJ Open Diabetes Research & Care
is an open access diabetes journal from the ADA and BMJ that strives to publish innovative studies on diabetes in all disciplines and therapeutic areas as quickly and transparently as possible.
Impact Factor: 4.186
Citescore: 4.2
All metrics >>
Latest Articles
Metabolism:
Non-efficacy of early intervention strategy for non-obese patients with early-onset gestational diabetes mellitus: solely based on the short-term outcomes3 June 2023
Metabolism:
Fecal microbiota transplantation ameliorates type 2 diabetes via metabolic remodeling of the gut microbiota in db/db mice30 May 2023
Epidemiology/Health services research:
Food insecurity, SNAP participation and glycemic control in low-income adults with predominantly type 2 diabetes: a cross-sectional analysis using NHANES 2007-2018 data23 May 2023
Cardiovascular and metabolic risk:
Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study22 May 2023
Cardiovascular and metabolic risk:
Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study15 May 2023
Most Read Articles
Cardiovascular and metabolic risk:
Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes11 October 2022
Cardiovascular and metabolic risk:
How sweet is your love? Disentangling the role of marital status and quality on average glycemic levels among adults 50 years and older in the English Longitudinal Study of Ageing6 February 2023
Emerging technologies, pharmacology and therapeutics:
Update on the management of diabetes in long-term care facilities20 July 2022
Epidemiology/Health services research:
Association of hemoglobin A1c time in range with risk for diabetes complications12 July 2022
Emerging technologies, pharmacology and therapeutics:
Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, …15 November 2022
Cardiovascular and Metabolic Risk
Cardiovascular and metabolic risk:
Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study22 May 2023
Cardiovascular and metabolic risk:
Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study15 May 2023
Cardiovascular and metabolic risk:
Higher burden of cardiometabolic and socioeconomic risk factors in women with type 2 diabetes: an analysis of the Glycemic Reduction Approaches in Diabetes (GRADE) baseline cohort24 April 2023
Cardiovascular and metabolic risk:
Development and validation of a multivariable genotype-informed gestational diabetes prediction algorithm for clinical use in the Mexican population: insights into susceptibility mechanisms21 April 2023
Cardiovascular and metabolic risk:
Paediatric Obesity Evaluation for Metabolic Susceptibility (POEMS)19 April 2023
Altmetrics
